Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals develops innovative therapies to improve the lives of patients struggling with unintentional cannabis poisoning and acute cannabinoid intoxication. They focus on developing best-in-class therapeutics for treating acute cannabinoid toxicities, particularly in children. The company prioritizes the development of Selonabant.
Registro Oficial
Última verificación: 1/2/2026
Análisis de Calidad IA
Desglose de Puntuación de Confianza
Enlaces Rápidos
Destacados del sitio web
🌟 Empresas similares de confianza
PLUS THERAPEUTICS, INC.
Plus Therapeutics is a clinical-stage pharmaceutical company focusing on developing targeted radiotherapeutics for cancer treatment. They leverage novel drug formulations and technologies to deliver a single, safe, and effective dose of radiation directly to the tumor. Their focus is on improving the treatment of challenging cancers in adults and children, aiming to lengthen and improve lives.
OVATION SCIENCE INC.
Ovation Science Inc. leverages its patented Invisicare® technology to enhance the delivery of drugs and ingredients through the skin. They provide pharmaceutical-grade technology to global licensees, resulting in high-quality, efficacious topical and transdermal products. They are positioned as an innovative player in the drug development and cannabis industries.
SHIONOGI & CO LTD
Shionogi is a pharmaceutical company focused on research and development of innovative medicines. They are particularly committed to addressing antimicrobial resistance (AMR) and improving access to healthcare. Shionogi provides a wide range of pharmaceutical products and services, and is known for its research in infectious diseases and other therapeutic areas. The company has a long history and a strong commitment to sustainability.